Comparative proteomics of Listeria monocytogenes strains of food and clinical origin reveals strain-specific adaptation mechanisms
Frontiers in Microbiology · 26.08.2025 · 16
DOI: 10.3389/fmicb.2025.1640990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 26.08.2025. Verfasst von Ivanka Krasteva und 14 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Listeria monocytogenes is a foodborne pathogen capable of surviving in diverse environments, including food-processing settings and the human host. This study compared the proteomic profiles of two Listeria monocytogenes strains grown at 37 °C to simulate host-associated conditions: a hypovirulent, food-derived strain and a hypervirulent strain isolated from a human clinical sample. This approach enabled the identification of temperature-induced changes in virulence factors, providing valuable insights into molecular determinants of pathogenicity and potential intervention strategies. Mass spectrometry identified 954 proteins, 642 of which were predicted to be immunogenic. Among these, 128 were unique to the food-derived strain (F), and 29 were specific to the clinical strain (H). Functional analysis revealed that F-specific proteins were primarily involved in terpenoid backbone biosynthesis and the production of secondary metabolites, processes associated with membrane integrity, stress resistance, and metabolic adaptation. In contrast, H-specific proteins were related to acid resistance and bacteriophage-associated functions. Although the number of H-specific immunogenic proteins was insufficient for statistically significant enrichment analysis, six highly interconnected proteins were identified. These results suggest that L. monocytogenes undergoes targeted proteomic remodeling under host-mimicking conditions, facilitating its transition from a food contaminant to invasive pathogen. The identification of immunogenic, strain-specific proteins enhances our understanding of bacterial adaptation and virulence, with important implications for diagnostics, surveillance, and targeted mitigation efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy.
- Ospedale "San Salvatore" - L'Aquila - ASL1 Abruzzo, L'Aquila, Italy.
Zitieren
APA
Krasteva, I., Schirone, M., Di Pancrazio, C., Manocchia, F., D'Onofrio, F., Maggetti, M., Perletta, F., Pomilio, F., Bruno, G., Torresi, M., Centorotola, G., Paparella, A., Sacchini, F., D'Alterio, N., & Luciani, M. (2025). Comparative proteomics of Listeria monocytogenes strains of food and clinical origin reveals strain-specific adaptation mechanisms. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1640990
Vancouver
Krasteva I, Schirone M, Di Pancrazio C, Manocchia F, D'Onofrio F, Maggetti M, et al. Comparative proteomics of Listeria monocytogenes strains of food and clinical origin reveals strain-specific adaptation mechanisms. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1640990
BibTeX
@article{Krasteva2025,
author = {Krasteva, Ivanka and Schirone, Maria and Di Pancrazio, Chiara and Manocchia, Francesco and D'Onofrio, Federica and Maggetti, Marta and Perletta, Fabrizia and Pomilio, Francesco and Bruno, Gianfranco and Torresi, Marina and Centorotola, Gabriella and Paparella, Antonello and Sacchini, Flavio and D'Alterio, Nicola and Luciani, Mirella},
title = {Comparative proteomics of Listeria monocytogenes strains of food and clinical origin reveals strain-specific adaptation mechanisms},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1640990}
}
EUVIMED